[ad_1]
NEW ORLEANS — Researchers had hoped lately {that a} protein known as GPRC5D may provide a brand new method to get the immune system to search out and destroy a number of myeloma cells. Now, the outcomes of a Part 2 examine on a bispecific antibody concentrating on this protein gives affirmation.
The info, offered Saturday on the annual American Society of Hematology conferences, wowed a crowd of attendees, together with clinicians who started excitedly imagining easy methods to use the brand new drug in observe.
[ad_2]
Source link
